Table 2.

Symptoms and treatments profile.

	Meta-analysis of case series studies					Descriptive data analysis of case reports
Outcomes	Meta-analysis					Individual data analysis
	N	I2	P(%)	95 %CI		P(%)
Maternal signs and symptoms
Fever	26	83.67 %	0.58	0.48	0.67	0.64
Cough	26	85.49 %	0.52	0.42	0.62	0.60
Lymphopenia	18	91.40 %	0.46	0.31	0.62	0.38
Asymptomatic	20	84.94 %	0.09	0.02	0.19	0.09
Dyspnea	25	89.11 %	0.17	0.09	0.28	0.36
Fatigue	21	77.16 %	0.06	0.01	0.12	0.16
Diarrhea	23	48.86 %	0.03	0.01	0.06	0.04
Sore throat	22	66.57 %	0.03	0.01	0.08	0.22
Myalgia	21	83.25 %	0.06	0.01	0.14	0.24
Elevated C-reactive protein	18	89.58 %	0.48	0.34	0.63	0.55
Maternal comorbidities
Gestational diabetes	20	39.69 %	0.04	0.02	0.07	0.21
Preeclampsia	20	25.56 %	0.04	0.02	0.07	0.08
Other*	20	63.71 %	0.13	0.08	0.2	0.44
Treatments for COVID-19 infection
Antibiotics	17	96.79 %	0.67	0.41	0.89	0.63
Antivirals	17	96.44 %	0.48	0.24	0.73	0.69
Oxygen support	18	90.99 %	0.31	0.19	0.46	0.71

^*Other included polycystic ovary syndrome, hypothyroidism, hyperthyroidism etc.; P: proportion; CI: confidence interval; I²: measures of heterogeneity across studies; COVID: coronavirus disease.